Cita APA

Rivero, R., Esteva, M. I., Huang, E., Colmegna, L., Altcheh, J. M., Grossmann, U., & Ruiz, A. M. (2023). ELISA F29 –A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment. Web

Citación estilo Chicago

Rivero, Rocío, Mónica Inés Esteva, Erya Huang, Leylen Colmegna, Jaime Marcelo Altcheh, Ulrike Grossmann, and Andrés Mariano Ruiz. ELISA F29 –A Therapeutic Efficacy Biomarker in Chagas Disease: Evaluation in Pediatric Patients Treated With Nifurtimox and Followed for 4 Years Post-treatment. 2023.

Cita MLA

Rivero, Rocío, et al. ELISA F29 –A Therapeutic Efficacy Biomarker in Chagas Disease: Evaluation in Pediatric Patients Treated With Nifurtimox and Followed for 4 Years Post-treatment. 2023.